Literature DB >> 12873626

Chronic opioid exposure produces increased heroin self-administration in rats.

John R Walker1, Scott A Chen, Heather Moffitt, Charles E Inturrisi, George F Koob.   

Abstract

The purpose of this study was to determine the significance of chronic opioid exposure on the level of heroin self-administration in the rat. Rats were divided into morphine (M, subcutaneous morphine pellets) and placebo (P, subcutaneous placebo pellets) groups and self-administered several different doses of heroin during daily limited access 1-h sessions and prolonged access 8-h sessions. No effects on heroin self-administration occurred when the rats were implanted with morphine pellets and allowed to self-administer heroin in a limited access paradigm (1-h group). However, rats with morphine pellet implantation showed a rapid escalation (Days 0-3 post-pellet) in heroin self-administration in the more prolonged access group (8 h group) compared to placebo-pelleted animals also with 8-h access. Ultimately, placebo-pelleted 8-h exposed animals showed an escalation in heroin self-administration but this effect was delayed until Days 16-18 post-pellet. These results suggest that passive administration of morphine sufficient to produce and maintain dependence facilitates escalation in heroin intake.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873626     DOI: 10.1016/s0091-3057(03)00094-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Predisposing effects of neonatal visceral pain on abuse-related effects of morphine in adult male Sprague Dawley rats.

Authors:  Andrew P Norwood; Elie D Al-Chaer; William E Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

2.  Extended heroin access increases heroin choices over a potent nondrug alternative.

Authors:  Magalie Lenoir; Lauriane Cantin; Nathalie Vanhille; Fuschia Serre; Serge H Ahmed
Journal:  Neuropsychopharmacology       Date:  2013-01-15       Impact factor: 7.853

3.  Measuring the incentive value of escalating doses of heroin in heroin-dependent Fischer rats during acute spontaneous withdrawal.

Authors:  Katharine M Seip; Brian Reed; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2011-07-07       Impact factor: 4.530

4.  The effect of intermittent alcohol vapor or pulsatile heroin on somatic and negative affective indices during spontaneous withdrawal in Wistar rats.

Authors:  Angela M Williams; Daniel J Reis; Alexa S Powell; Louis J Neira; Kathryn A Nealey; Cole E Ziegler; Nina D Kloss; Jessica L Bilimoria; Chelsea E Smith; Brendan M Walker
Journal:  Psychopharmacology (Berl)       Date:  2012-03-31       Impact factor: 4.530

5.  A vaccine strategy that induces protective immunity against heroin.

Authors:  G Neil Stowe; Leandro F Vendruscolo; Scott Edwards; Joel E Schlosburg; Kaushik K Misra; Gery Schulteis; Alexander V Mayorov; Joseph S Zakhari; George F Koob; Kim D Janda
Journal:  J Med Chem       Date:  2011-06-30       Impact factor: 7.446

6.  Escalation patterns of varying periods of heroin access.

Authors:  Leandro F Vendruscolo; Joel E Schlosburg; Kaushik K Misra; Scott A Chen; Thomas N Greenwell; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2011-03-23       Impact factor: 3.533

7.  Age-dependent morphine intake and cue-induced reinstatement, but not escalation in intake, by adolescent and adult male rats.

Authors:  James Doherty; Yvonne Ogbomnwan; Bonnie Williams; Kyle Frantz
Journal:  Pharmacol Biochem Behav       Date:  2008-12-03       Impact factor: 3.533

8.  Self administration of heroin and cocaine in morphine-dependent and morphine-withdrawn rhesus monkeys.

Authors:  Lisa R Gerak; Ruggero Galici; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2009-02-05       Impact factor: 4.530

Review 9.  Factors mediating pain-related risk for opioid use disorder.

Authors:  Arbi Nazarian; S Stevens Negus; Thomas J Martin
Journal:  Neuropharmacology       Date:  2021-01-30       Impact factor: 5.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.